Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOL-DP-o-04 for Diabetic Neuropathy
NCT04082000Phase 2Terminated
- Sponsor
- BOL Pharma
- Start
- Apr 2019
- Primary completion
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of BOL-DP-o-04 in diabetic neuropathy, sponsored by BOL Pharma. Started Apr 2019; status: terminated.
02
Drugs
BOL-DP-o-04
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT04082000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04082000.